Progress in the Application of Esketamine During the Perioperative Period
Drug Design, Development and Therapy · 2026-02 · Volume 20 · 1-18
DOI: 10.2147/dddt.s579462 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-02. Verfasst von Jia-Sheng Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China. Hauptthemen laut MEDLINE: Ketamine, Analgesics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Esketamine is the S-enantiomer of ketamine. As a potent NMDA receptor antagonist with high affinity, it exhibits sedative, analgesic, and antidepressant properties, among others. Compared with racemic ketamine, esketamine demonstrates approximately twice the potency, along with several advantages: a rapid onset of action, mild respiratory depression, and fewer adverse psychiatric effects. In recent years, the perioperative application of esketamine has garnered increasing attention. It has demonstrated potential application value in clinical practice, particularly in obstetric anesthesia, pediatric surgical anesthesia, orthopedic surgical anesthesia, painless diagnostic and therapeutic procedures, and special clinical scenarios. The pharmacological mechanism of esketamine has not been fully elucidated to date, and research on its perioperative application remains relatively limited. High quality evidence from large-sample, multicenter studies is scarce, and no unified standard has been established for its administration regimens and dosages. Nonetheless, this paper provides a summary of the pharmacological properties, potential mechanisms of action, and current clinical applications of esketamine across diverse clinical scenarios, with the overarching goal of providing evidence to support its rational use in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
- Department of Anesthesiology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
- Ganzhou Key Laboratory of Anesthesiology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
ORCID-Profile: Jia-Sheng Wang, Qian Hu, Wei-Dong Liang, Lifeng Wang
Zitieren
APA
Wang, J. S., Hu, Q., Cao, R. Y., Liu, W. K., Guo, M. L., Lin, Y., Zhong, M. L., Liang, W. D., & Wang, L. (2026). Progress in the Application of Esketamine During the Perioperative Period. Drug Design, Development and Therapy, Volume 20, 1-18. https://doi.org/10.2147/dddt.s579462
Vancouver
Wang JS, Hu Q, Cao RY, Liu WK, Guo ML, Lin Y, et al. Progress in the Application of Esketamine During the Perioperative Period. Drug Design, Development and Therapy. 2026;Volume 20:1-18. doi:10.2147/dddt.s579462
BibTeX
@article{Wang2026,
author = {Wang, Jia-Sheng and Hu, Qian and Cao, Rui-Yang and Liu, Wen-Kai and Guo, Ming-Ling and Lin, Yong and Zhong, Mao-Lin and Liang, Wei-Dong and Wang, Lifeng},
title = {Progress in the Application of Esketamine During the Perioperative Period},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--18},
doi = {10.2147/dddt.s579462}
}
EUVIMED